Arterial Chemoembolization/Embolization and Early Complications after Hepatocellular Carcinoma Treatment: A Safe Standardized Protocol in Selected Patients with Child Class A and B Cirrhosis

Journal of Vascular and Interventional Radiology

Volumn 20, Issue 7, 2009, Pages 896-902

  Pietrosi, Giada ^a   Miraglia, Roberto ^a   Luca, Angelo ^a   Vizzini, Giovanni Battista ^a   Fili', Daniela ^a   Riccardo, Volpes ^a   D'Antoni, Adele ^a   Petridis, Ioannis ^a   Maruzzelli, Luigi ^a   Biondo, Domenico ^a   Gridelli, Bruno ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; EPIRUBICIN; GELATIN; GELFOAM; IODINATED POPPYSEED OIL; LAMIVUDINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTERY INJURY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BODY SURFACE; BRAIN DISEASE; CANCER THERAPY; CHEMOEMBOLIZATION; CHOLECYSTITIS; CLASS A LIVER CIRRHOSIS; CLASS B LIVER CIRRHOSIS; CLINICAL PROTOCOL; CONSTITUTIONAL SYNDROME; DISEASE SEVERITY; DIVERTICULITIS; DRUG DOSE REDUCTION; FEMALE; HEPATIC ARTERY DAMAGE; HEPATITIS B; HUMAN; LABORATORY TEST; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALAISE; MALE; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; SCORING SYSTEM; SEPSIS; STANDARD; SYNDROME; UNIVARIATE ANALYSIS; VARIX BLEEDING; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; FIBROSIS; HUMANS; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67449086535     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.03.032     Document Type: Article

References (24)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics 2002. CA Cancer J Clin 55 (2005) 74-108
2. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
3. Marelli L., Stigliano R., Triantos C., et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective?. A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30 (2007) 6-25
4. Groupe d'Etude et de traitement du Carcinome hepatocellulaire. A comparison of Lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
5. Ngan H., Lai C.L., Fan S.T., Lai E.C., Yuen W.K., and Tso W.K. Transcatheter arterial chemoembolization in inoperable hepatocellular carcinoma: four-year follow up. J Vasc Interv Radiol 7 (1996) 419-425
6. Pelletier G., Roche A., Ink O., et al. A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma. J Hepatol 11 (1990) 181-184
7. Llado' L., Virgili J., Figueras J., et al. A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Cancer 88 (2000) 50-57
8. Poon R.T., Ngan H., Lo C.M., Liu C.L., and Wong J. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73 (2000) 109-114
9. Llovet J.M., Real M.I., Montana X., et al. Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
10. Chan A.O., Yuen M.F., Hui C.K., Tso W.K., and Lai C.L. A prospective study regarding the complications of transcatheter intraarterial Lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 94 (2002) 1747-1752
11. Chen M.S., Li J.Q., Zhang Y.Q., et al. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 8 (2002) 74-78
12. Hsieh C.B., Chang H.M., Chen T.W., et al. Comparison of transcatheter arterial chemoembolization, laparoscopic radiofrequency ablation, and conservative treatment for decompensated cirrhotic patients with hepatocellular carcinoma. World J Gastroenterol 10 (2004) 505-508
13. Liem M.S., Poon R.T., Lo C.M., Tso W.K., and Fan S.T. Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol 11 (2005) 4465-4471
14. Kiely J.M., Rilling W.S., Touzios J.G., et al. Chemoembolization in patients at high risk: results and complications. J Vasc Interv Radiol 17 (2006) 47-53
15. Brown D.B., Gould J.E., Gervais D.A., et al. Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria. J Vasc Interv Radiol 18 (2007) 1469-1478
16. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
17. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35 (2001) 421-430
18. Llovet J.M., Bustamante J., Castells A., et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of the therapeutic trials. Hepatology 29 (1999) 62-67
19. Northup P.G., Wanamaker R.C., Lee V.D., Adams R.B., and Berg C.L. Model for end-stage liver disease (MELD) predicts nontransplant surgical mortality in patients with cirrhosis. Ann Surg 242 (2005) 244-251
20. Vizzini G.B., Luca A., and Marino I. Hepatitis B virus reactivation after a single session of transarterial chemoembolization in patients with hepatocellular carcinoma. Research letter. Ann Intern Med 138 (2003) 691-692
21. Miraglia R., Pietrosi G., Maruzzelli L., et al. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma. World J Gastroenterol 13 (2007) 2952-2955
22. Savastano S., Miotto D., Casarrubea G., Teso S., Chiesura-Corona M., and Feltrin G.P. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol 28 (1999) 334-340
23. Varela M., Real M.I., Burrel M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and epirubicin pharmacokinetics. J Hepatol 46 (2007) 474-481
24. Malagari K., Chatzimichael K., Alexopoulou E., et al. Transarterial chemoembolization of unresectable hepatocellular carcinoma (HCC) with drug eluting beads (DEB): results of an open label study of 62 patients. Cardiovasc Intervent Radiol 31 (2008) 269-280